Metabolic Dysfunction-Associated Steatotic Liver Disease

MASLD Management

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a condition in which excess fat accumulates in the liver in association with metabolic risk factors. It is commonly linked to obesity, type 2 diabetes, insulin resistance, high cholesterol and high blood pressure. Early identification and appropriate MASLD management are important to reduce the risk of liver inflammation, progressive scarring and other metabolic complications.

Understanding MASLD and Its Risk Factors

MASLD may develop gradually and often does not cause noticeable symptoms during its early stages. Many individuals discover the condition through routine blood investigations or an abdominal ultrasound. Without appropriate monitoring, some patients may develop metabolic dysfunction-associated steatohepatitis (MASH), which can lead to liver fibrosis and, in advanced cases, cirrhosis.

Common risk factors associated with MASLD include:

  • Overweight and obesity.
  • Type 2 diabetes and insulin resistance.
  • High cholesterol and elevated triglyceride levels.
  • High blood pressure.
  • Metabolic syndrome.
  • Physical inactivity and unhealthy dietary habits.

Comprehensive Liver and Metabolic Assessment

Effective MASLD management begins with evaluating liver health and identifying associated metabolic conditions. A detailed medical assessment helps determine individual risk factors and the need for further investigations.

Depending on the patient’s medical history and clinical findings, evaluation may include:

  • Review of medical history, lifestyle and existing health conditions.
  • Assessment of body weight, BMI and metabolic risk factors.
  • Liver function tests to evaluate liver enzyme levels.
  • Blood glucose and HbA1c testing.
  • Lipid profile to assess cholesterol and triglyceride levels.
  • Abdominal ultrasound to identify fatty changes in the liver.
  • Fibrosis risk assessment and additional liver evaluation when indicated.

These investigations help assess the condition and guide appropriate medical recommendations.

Lifestyle Modification and Weight Management

Lifestyle changes are an important part of managing MASLD. The approach focuses on improving metabolic health, reducing excess liver fat and addressing conditions that may contribute to disease progression.

Management guidance may include:

  • Gradual and sustainable weight reduction where appropriate.
  • Balanced nutrition and portion control.
  • Regular physical activity based on individual fitness.
  • Improved blood sugar and cholesterol control.
  • Management of high blood pressure.
  • Healthy sleep habits and reduced sedentary behaviour.

Monitoring and Long-Term Liver Health

MASLD requires appropriate follow-up to monitor liver health and associated metabolic conditions. Regular medical reviews and investigations may help assess progress and identify signs of disease progression. Medication may be considered for associated conditions or specific liver-related indications based on individual assessment.

Comprehensive MASLD Management

MASLD management focuses on comprehensive medical evaluation, metabolic risk assessment and personalised lifestyle guidance. The aim is to support liver health, manage associated conditions and help reduce the risk of long-term complications through appropriate medical care and continued monitoring.

Powered by Joinchat